These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 9006320)
21. The tuberous sclerosis 2 gene is expressed at high levels in the cerebellum and developing spinal cord. Geist RT; Gutmann DH Cell Growth Differ; 1995 Nov; 6(11):1477-83. PubMed ID: 8562486 [TBL] [Abstract][Full Text] [Related]
22. Alternative splicing of the tuberous sclerosis 2 (TSC2) gene in human and mouse tissues. Xu L; Sterner C; Maheshwar MM; Wilson PJ; Nellist M; Short PM; Haines JL; Sampson JR; Ramesh V Genomics; 1995 Jun; 27(3):475-80. PubMed ID: 7558029 [TBL] [Abstract][Full Text] [Related]
23. Tuberous sclerosis causing mutants of the TSC2 gene product affect proliferation and p27 expression. Soucek T; Rosner M; Miloloza A; Kubista M; Cheadle JP; Sampson JR; Hengstschläger M Oncogene; 2001 Aug; 20(35):4904-9. PubMed ID: 11521203 [TBL] [Abstract][Full Text] [Related]
24. Tuberous sclerosis genes regulate cellular 14-3-3 protein levels. Hengstschläger M; Rosner M; Fountoulakis M; Lubec G Biochem Biophys Res Commun; 2003 Dec; 312(3):676-83. PubMed ID: 14680818 [TBL] [Abstract][Full Text] [Related]
25. Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis. Wenzel HJ; Patel LS; Robbins CA; Emmi A; Yeung RS; Schwartzkroin PA Acta Neuropathol; 2004 Aug; 108(2):97-108. PubMed ID: 15185103 [TBL] [Abstract][Full Text] [Related]
26. Ezrin and moesin expression within the developing human cerebrum and tuberous sclerosis-associated cortical tubers. Johnson MW; Miyata H; Vinters HV Acta Neuropathol; 2002 Aug; 104(2):188-96. PubMed ID: 12111362 [TBL] [Abstract][Full Text] [Related]
27. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. Wienecke R; König A; DeClue JE J Biol Chem; 1995 Jul; 270(27):16409-14. PubMed ID: 7608212 [TBL] [Abstract][Full Text] [Related]
28. The cellular response to ectopic overexpression of the tuberous sclerosis genes, TSC1 and TSC2: a proteomic approach. Hengstschläger M; Rosner M; Fountoulakis M; Lubec G Int J Oncol; 2005 Sep; 27(3):831-8. PubMed ID: 16077935 [TBL] [Abstract][Full Text] [Related]
29. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis. Maheshwar MM; Cheadle JP; Jones AC; Myring J; Fryer AE; Harris PC; Sampson JR Hum Mol Genet; 1997 Oct; 6(11):1991-6. PubMed ID: 9302281 [TBL] [Abstract][Full Text] [Related]
30. Expression and prognostic value of tuberous sclerosis complex 2 gene product tuberin in human pancreatic cancer. Kataoka K; Fujimoto K; Ito D; Koizumi M; Toyoda E; Mori T; Kami K; Doi R Surgery; 2005 Sep; 138(3):450-5. PubMed ID: 16213898 [TBL] [Abstract][Full Text] [Related]
31. A calmodulin binding site in the tuberous sclerosis 2 gene product is essential for regulation of transcription events and is altered by mutations linked to tuberous sclerosis and lymphangioleiomyomatosis. Noonan DJ; Lou D; Griffith N; Vanaman TC Arch Biochem Biophys; 2002 Feb; 398(1):132-40. PubMed ID: 11811958 [TBL] [Abstract][Full Text] [Related]
32. HMB-45 and tuberin in hamartomas associated with tuberous sclerosis. Kimura N; Watanabe M; Date F; Kitamoto T; Kumura I; Horii A; Nagura H Mod Pathol; 1997 Sep; 10(9):952-9. PubMed ID: 9310961 [TBL] [Abstract][Full Text] [Related]
33. Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice. Kobayashi T; Minowa O; Kuno J; Mitani H; Hino O; Noda T Cancer Res; 1999 Mar; 59(6):1206-11. PubMed ID: 10096549 [TBL] [Abstract][Full Text] [Related]
35. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Benvenuto G; Li S; Brown SJ; Braverman R; Vass WC; Cheadle JP; Halley DJ; Sampson JR; Wienecke R; DeClue JE Oncogene; 2000 Dec; 19(54):6306-16. PubMed ID: 11175345 [TBL] [Abstract][Full Text] [Related]
36. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model. Tsuchiya H; Orimoto K; Kobayashi K; Hino O Cancer Res; 1996 Feb; 56(3):429-33. PubMed ID: 8564946 [TBL] [Abstract][Full Text] [Related]
37. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. Jin F; Wienecke R; Xiao GH; Maize JC; DeClue JE; Yeung RS Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9154-9. PubMed ID: 8799170 [TBL] [Abstract][Full Text] [Related]
38. Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex. Ali M; Girimaji SC; Markandaya M; Shukla AK; Sacchidanand S; Kumar A Acta Neurol Scand; 2005 Jan; 111(1):54-63. PubMed ID: 15595939 [TBL] [Abstract][Full Text] [Related]
39. Reduction of expression of tuberin, the tuberous-sclerosis-complex-gene-2 product in tuberous sclerosis complex associated connective tissue nevi and sporadic squamous and basal cell carcinomas. Wienecke R; Klemm E; Karparti S; Swanson NA; Green AJ; DeClue JE J Cutan Pathol; 2002 May; 29(5):287-90. PubMed ID: 12100629 [TBL] [Abstract][Full Text] [Related]
40. Alterations in the rap1 signaling pathway are common in human gliomas. Gutmann DH; Saporito-Irwin S; DeClue JE; Wienecke R; Guha A Oncogene; 1997 Sep; 15(13):1611-6. PubMed ID: 9380414 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]